Manufacturers seek clarity on FDA’s drug shortage notification guidance
Regulatory NewsJeff Craven
APIsBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsSupply Chain ManagementRegulatory NewsJeff CravenAPIsBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsSupply Chain Management